| Three Months Ended March 31, | Twelve Months Ended March 31, | ||||||||||||||
| 2022 | 2021 | 2022 | 2021 | ||||||||||||
| Research and development expenses, as reported | $ | 259.1 | $ | 228.5 | $ | 989.1 | $ | 836.4 | |||||||
| Share-based compensation expense | (21.8 | ) | (26.8 | ) | (97.9 | ) | (96.8 | ) | |||||||
| Acquisition-related | (0.2 | ) | (0.2 | ) | (0.8 | ) | (0.4 | ) | |||||||
| Non-GAAP research and development expenses | $ | 237.1 | $ | 201.5 | $ | 890.4 | $ | 739.2 | |||||||
| Non-GAAP research and development expenses as a percentage of net sales | 12.9 | % | 13.7 | % | 13.1 | % | 13.6 | % | |||||||
Microchip Technology Announces Record Financial Results for Fourth Quarter and Fiscal Year 2022
 |  | More IC News
|
|
RECONCILIATION OF GAAP RESEARCH AND DEVELOPMENT EXPENSES TO NON-GAAP RESEARCH AND DEVELOPMENT EXPENSES
RELATED NEWS
